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Although big progress has been made in sample pretreatment over the last years, there are still considerable limitations when it
comestoovercomingcomplexityanddynamicrangeproblemsassociatedwithpeptideanalysesfrombiologicalmatrices.Beingthe
littlebrotherofproteomics,peptidomicsisarelativelynewﬁeldofresearchaimingatthedirectanalysisofthesmallproteins,called
peptides, many of which are not amenable for typical trypsin-based analytics. In this paper, we present an overview of diﬀerent
techniques and methods currently used for reducing a sample’s complexity and for concentrating low abundant compounds to
enable successful peptidome analysis. We focus on techniques which can be employed prior to liquid chromatography coupled
to mass spectrometry for peptide detection and identiﬁcation and indicate their advantages as well as their shortcomings when it
comes to the untargeted analysis of native peptides from complex biological matrices.
1.Introduction
Peptides are small (low molecular weight, LMW) proteins,
built up of amino acids connected by peptide bonds. The
shortest peptide is two amino acids long, and with increasing
length of the amino acid chain, the name changes from
peptide over polypeptide to protein, with a fuzzy border
between them. Also the International Union of Pure and
Applied Chemistry (IUPAC) has no clear weight or amino
acid chain length limit. A somewhat arbitrary but quite gen-
erally acknowledged deﬁnition puts the boundary between
ap e p t i d ea n dap r o t e i na tac h a i nl e n g t ho f5 0a m i n oa c i d s
(WIKIPEDIA). In literature, often pragmatic deﬁnitions are
used, such as “the small proteins typically running oﬀ a
typical 2D polyacrylamide gel” or “the small proteins with
zero or maximally one tryptic cleavage site”, and, therefore,
diﬀerent upper molecular weight limits for peptides can be
f o u n df r o m1 0k D aa n de v e nb e y o n d[ 1–6]. As proteomics is
for proteins, peptidomics is the comprehensive study of all
(native) peptides in a biological sample. In the last decade,
proteomics has gained increasing recognition as a reliable
and reproducible approach to study molecular processes in
high throughput at a global level. Recently, also peptidomics
is becoming more and more a “hot topic” as it is recognized
that peptides play complex regulatory roles in many if not
all biological processes, for example, intercellular signaling
[7, 8]. As such, peptide signals secreted into the extracellular
medium, reﬂect the state of a cell in a certain condition, and,
by deﬁnition, are potential biomarkers indicative for speciﬁc
physiological/pathological processes [9–11]. Currently, with
a general proteomic approach, it is possible to detect and
identify several hundreds to a few thousands of proteins
in a single experiment [12–14]. With modern mass spec-
trometers excelling in sensitivity and dynamic range, also
the cell’s peptidomes become much more comprehensively
accessible for analysis, and the discovery of novel biomarkers
becomes possible, such as in innovative cancer research.
For example, Ueda et al. [15] used size-exclusion-based2 Journal of Biomedicine and Biotechnology
enrichment of the peptidome in combination with label-free
quantitation by nano-LC-MS/MS for peptidome proﬁling in
lung carcinomas.
Body ﬂuids, especially blood serum or plasma, and, in
particularcases,(primary)cellculturemedia,serveastypical
and readily available sources for a “peptidomics-driven”
discovery of novel candidate disease biomarkers. However,
the detection of peptide biomarkers typically present at low
concentrations is hampered by the “masking” eﬀect caused
by a number of highly abundant proteins [11, 16–19]. The
large dynamic concentration range, in which peptides and
proteins are present in a biological system presents a major
bottleneck for peptidomic discovery of new biomarkers.
Figure 1 reﬂecting the large dynamic range of proteins and
peptides in human blood plasma is very illustrative in this
respect. Especially-the presence of albumin in a sample has
been shown to prevent the successful identiﬁcation of low-
abundance biomarkers in many peptidomic studies [17, 20,
21]. Hence, diﬀerent methods for capturing, partitioning,
fractionating, depleting, or enriching a sample have been
developed [22, 23].
Liquid chromatography (LC) coupled with tandem mass
spectrometry (MS/MS) is the analytical method of choice
in today’s proteomics and peptidomics research. Its major
beneﬁts include enhanced speciﬁcity (particularly over the
GC-MS technologies of 25 years ago, which had very limited
applicability for peptide separations), its potential for high-
throughput analyses, no requirement for expensive analyte-
speciﬁc reagents, high speed of assay development, and a
relatively low cost per assay (the instrument itself, however,
not being that cheap) [24].
In an ideal world, no sample preparation would be
required for the analysis of a sample as every manipulation
c a nl e a dt op r o b l e m ss u c ha sl o s so fs a m p l ea n d ,e v e n
worse,lossofquantiﬁability.Inparticular,fortheproteomic/
peptidomic analysis of native peptides, which typically do
not require protease (trypsin) digestion prior to LC-MS/MS
analysis, a so-called “top-down” approach seems logical.
However, as the complexity of samples still far exceeds the
capacity of currently available analytical systems, speciﬁc
sample preparation remains a crucial part of the analysis
in a whole. Peptidomics sample preparation is often time
consuming and laborious, involving multiple steps [25, 26].
In this paper, we present an overview of diﬀerent techniques
(see Figure 2) used for the simpliﬁcation of complex biolog-
ical samples and review advantages and possible problems
related to them (see Table 1). Our focus will be on bioﬂuids
such as blood, urine, or cerebrospinal ﬂuid (CSF), but
some issues related to the extracellular peptidome (part of
the so-called “secretome”) analysis of cultured cells will be
considered ﬁrst.
2. Sample PreparationTechniques
Used for the Analysisof
LMWSecretome/SignalingProteins
2.1. Cell Culture Conditions. Conditioned media are cell cul-
ture media whose cells have grown in for a certain period of
time. The cells “condition” the media by releasing/secreting
proteins, cytokines, and other biomolecules. As such, culture
supernatants or conditioned media (CM) can be considered
yet another (“body”) ﬂuid that can serve as a source for the
identiﬁcation of novel biomarkers, for example, in cancer
research [27]. It is important to note that in order to
promote a healthy growth of cells in culture, the culture
medium has to be supplemented with a standard cocktail of
nutrients and growth factors. In mammalian cell cultures,
this is typically achieved by the addition of a substantial
volume of fetal calf serum (FCS, up to 10% solution). When
studying the intracellular proteome (or peptidome), cells
a r ew a s h e ds e v e r a lt i m e sw i t hF C S - f r e ec e l lc u l t u r em e d i u m
and/or phosphate-buﬀered saline (PBS) prior to lysis to
reduce contamination of the sample with (bovine) serum
proteins. However, this is not possible when the extracellular
peptidome is under investigation. As a compromise, in most
studies, the medium containing FCS is replaced by FCS-free
medium or medium containing reduced amounts of FCS
just before starting the secretome experiment (e.g., giving
a biological/physiological stimulus). For adherent cells, it
is relatively easy and noninvasive to replace the medium.
However, when studying cells in suspension, several cen-
trifugation steps are required before the medium can be
replaced,whicharguablyisasourceofunnaturalstresstothe
cells, possibly even causing cell lysis. A main disadvantage of
working with reduced amounts of FCS (or no FCS at all) is
that also this is known to cause metabolic stress to the cells,
not seldom inducing cell death and consequently altering the
cell culture’s secretome [11, 28–34].
2.2. Gel Electrophoresis (1D-2D PAGE). A traditional well-
established technique in proteomics is one- or two-
dimensional (1D or 2D) polyacrylamide gel electrophoresis
(PAGE). Although more a protein than a typical peptide
separation technique, 1D and 2D PAGE are used in “pep-
tidomics” workﬂows as well, particularly when targeting
larger (poly)peptides or proteins. The latter can then be
analyzed by MS after extraction from the gel as proteolytic
fragments, after in-gel digestion. Denaturing agents, such
as SDS, are used to unfold the macromolecules and dis-
rupt noncovalent intra- and intermolecular protein/protein
interactions. SDS PAGE is a rather simple technique and,
above all, very robust. Its poor resolving power, however,
often poses a problem in the analysis of complex mixtures.
1D and particularly 2D PAGE are employed to increase
the depth of proteome/peptidome analysis, that is, through
fractionation of the sample components and removal of
LMW impurities, particularly salts, which interfere with
subsequent MS analyses [35–41].
2D PAGE is very sensitive predominantly to molecular
chargesofaprotein(bytheisoelectricfocusingstep),making
it a very eﬀective method to reveal/separate certain post-
translationalmodiﬁcationslikephosphorylations,sulfations,
or glycosilations. Limitations are that proteins/peptides with
extreme pI values cannot be separated and that the smaller
peptides are typically not retained in the second (MW sep-
aration) dimension. 2D PAGE followed by in-gel digestion
is relatively time consuming and laborious. The dynamicJournal of Biomedicine and Biotechnology 3
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Figure 1: Illustrative iceberg representation of high dynamic range of proteins found in blood, showing various classes of proteins and
peptides (ﬁgurecomposed of literature data [21] and others).Four arbitraryassemblies of proteins/peptides can be made, and representative
species are indicated. Iceberg tip contains abundant classical plasma proteins detectable in 1μL of sample or less. Tissue leakage proteins
typically require, at least, 1mL plasma volumes (typically after depletion of interfering abundant proteins), and concentration ranges of
secreted signal peptides/proteins like insulin, somatotropin are yet another 3 orders of magnitude lower. Interleukins and other cytokines
really push current MS systems to their very limit, whereas other neurosecretory signal peptides require extensive concentration steps to
reach levels detectable by MS.
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Figure 2: Schematic overview of methods and techniques used in proteome and peptidome analyses for sample preparation prior to LC
MS/MS.4 Journal of Biomedicine and Biotechnology
Table 1: Summary of the strengths and weaknesses of analytical tools used in peptidome research as discussed in this review. Abbreviations:
IEX: ion exchange; LC: liquid chromatography; MWCO: molecular weight cut-oﬀ; OS: organic solvent extraction; PAGE: polyacrylamide
gel electrophoresis; RAM: restricted access material; RP: reversed phase; SPE: solid phase extraction; UF: ultraﬁltration; SEC: size exclusion
chromatography.
Technique Strengths Weaknesses
Depletion
(i) Removes highly abundant “household”
proteins, allowing a “deeper” look into the
peptidome
(i) Requires costly antibody columns
(ii) Each protein to be removed requires a diﬀerent speciﬁc
antibody
(iii) Loss of peptides by nonspeciﬁc binding
PAGE
(i) Traditional well-established method
(ii) able to separate isoforms or PTMs
(iii) able to remove low molecular organic
and inorganic impurities
(i) Unsuitable for highly complex samples, poor dynamic range
(ii) Poor resolving power
(iii) Proteins/peptides with extreme pI values cannot be separated
(iv) The smallest peptides are not retained in MW separation
dimension
(v) Very time consuming and laborious
(vi) Low dynamic range
OFFGel (i) Eﬀective prefractionation tool
(ii) Medium resolution
(i) Postconcentration is required low resolution
(ii) No MWCO discrimination
(iii) long separation times
UF
(i) Fast
(ii) Inexpensive
(iii) Easy to automate
(i) Variable quality and reproducibility of commercial devices
(ii) Loss of hydrophobic peptides by nonspeciﬁc binding
LC
(SPE/RP/IEX)
(i) High resolution
(ii) Directly compatible with MS
(iii) High sensitivity in nanoLC
(iv) SPE ﬂexible, easy to automate
(v) Eﬃcient preconcentration
(i) Extensive method development for each speciﬁc matrix is
required
SEC (i) High resolving power
(ii) Reproducible (i) Loading limited by small injection volume
RAM
(i) Eﬀective removal of HMW compounds
(ii) Relatively large injection volumes
(iii) Analysis of untreated sample matrices possible
(iv) Easy to automate
(v) Online RAM coupled to (nano-)LC-MS/MS
possible
(i) Complicated LC setup
(ii) Extensive application directed method development and
optimization required
OS (i) Easy to operate
(ii) Inexpensive (i) Tedious to perform
range for detection in 2D PAGE is 102–104, which is less than
the protein expression range observed in biological systems.
In order to achieve the detection of low abundant proteins,
moreproteinneedstobeloaded.Suchhigherloads,however,
often further compromise the technique’s resolution due to
spot fusion and comigration [19, 21, 39, 42–46].
Important in PAGE is the visualization of the separated
proteins, although selected areas of a gel can be processed
for MS from unstained preparative gels after comparison/
alligning with an analytical reference or master gel.
The most commonly used visible stains are Coomassie
brilliant blue (CBB) and silver nitrate staining. CBB staining
is easy, MS compatible, and linear over, at least, one order
of magnitude, so it is usable for quantiﬁcation to a limited
extent. Silver nitrate is a more sensitive staining method—
0.5ng versus 50ng for CBB—but the staining procedure is
more labor intensive and has a more limited linear range
(due to its polychrome results). Although widely regarded
as the standard of rigor by which all other “ultrasensitive”
staining methods are judged, silver staining remains quite
a complex and variable protein-gel-staining methodology,
with many dozens of published protocols, all of them
requiring several steps. Silver staining quantitation is never
simple,duetothecomplexpolychromaticnatureofthecolor
development and to considerable diﬀerences in response
factors between diﬀerent proteins. Fluorescent dyes are also
popular to visualize proteins in gels; however, they are
not cheap reagents and require expensive scanners/image
analyzers. They exhibit detection sensitivity rivaling that of
silver staining, with workﬂow advantages similar to CBB
staining. Fluorescence oﬀers linear quantitation ranges 10–
100-fold greater than other colorimetric methods [47–50].
2.3. Oﬀ-Gel and Gel-Free Separation. Because of the limi-
tations associated with gel-based techniques, recently with
respect to detection of the smaller proteins and peptides
(see above), attention has gone to oﬀ-gel methods for pep-
tide/protein separations, in particular in solution-pI-based
peptide separations without the need for carrier ampholytes.
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gradient (IPG) gel, which is sealed against a multichamber
frame that contains both sample and focusing solutions.
The sample is separated by migration through the gel,
followed by diﬀusion into the well adjacent to the section
of the IPG strip. It allows for multiple samples to run
simultaneously and requires only small sample volume and
no prior sample cleanup. Disadvantages are that it has a
ratherlongseparationtimeandrequiresaninsulatedcooling
system [51–53]. Cologna et al. [52] recently described a
variation of the mostly used “OFFGEL” system (Agilent
Technologies, USA). Their device allows customization of
the number of wells or the pH gradient. Oﬀ-gel separation
has not only shown applicability for proteins but also for
peptides.Hubneretal.[54]comparedthetechniquetoin-gel
digestion and found that using peptide oﬀ-gel separation led
to a third more protein/peptide identiﬁcations Comparing
oﬀ-gel separation to reversed phase liquid chromatography
(RPLC) at high pH, Manadas et al. [55] conclude that RPLC
leads to the identiﬁcation of more peptides and also more
unique peptides.
In general, oﬀ-gel separation has clear advantages over
a gel-based approach with respect to focusing and concen-
trating peptides, but it still requires further optimization
to reach the same level of identiﬁcations as an RPLC-based
separation.
2.4. Speciﬁc Depletion of Highly Abundant Sample Proteins.
Many diﬀerent approaches exist to separate proteins based
on their biochemical and biophysical properties such as
molecular weight, mass, and hydrophobicity. However, these
separation methods are not protein selective. Another way
to reduce a sample’s complexity is to speciﬁcally remove
the most abundant protein(s), by doing (immuno-) aﬃnity
capturing [17, 20, 32, 39, 56–61].
Depletionofhighlyabundantproteinscanbedonebased
on dyes or on antibodies. An example is the removal of
albumin from serum, plasma, or cell culture samples. The
mostuseddyeforremovalofalbuminisCibacronblue(often
in combination with protein G for the removal of IgG).
This dye however does not only show aﬃnity for albumin
but also for NAD, FAD, and ATP binding sites of proteins,
which often results in the unwanted removal of proteins of
interest [62–64]. Several comparisons have been made on
Cibacron-blue-based depletion of highly abundant proteins
fromacomplexsample versusimmunodepletion ofthe same
sample. The overall conclusion is that the dye method is
less performant than the immuno-based aﬃnity removal: it
doesnotonlyincompletelybindallalbuminfromthesample
(lower eﬃcacy), but it also appears to remove a substantial
portion of proteins other than the targeted albumin (lower
speciﬁcity) [62, 65, 66].
Immunodepletion based on monoclonal antibodies
(mAbs) is generally not preferred as, besides being very
expensive, these antibodies typically remove only proteins or
protein fragments with the speciﬁc targeted epitope, whereas
otherfragmentsoftheproteinremainuntouched.Therefore,
immunodepletion systems are generally based on polyclonal
IgG and/or IgY antibodies, targeting multiple epitopes
on the same proteins. Moreover, a mixture of polyclonal
antibodies to distinct proteins are nowadays commonly used
forremovingmultiplehighlyabundantproteinsatonce[62].
Antibody-based depletion of a sample can be performed
in (low-pressure) spin cartridges or (high-pressure) liquid
chromatography (LC) columns.
When using antibodies, one has to consider the number
of proteins that has to be depleted from the sample. Depend-
ing on the system used, it is possible to remove between 1
and 20 abundant proteins. Roche et al. compared several
systems which deplete for diﬀerent amounts of proteins
[60]. They observed that increasing the number of depleted
proteins from 12 to 20 had only little beneﬁcial eﬀect
and could in fact even increase the removal of peptides
and proteins of interest which are associated with the
abundant proteins. Also Tu et al. [67] did a comparison of
2 types of multiple aﬃnity removal system (MARS; Agilent
Technologies, Inc.) depleting, respectively, 7 (MARS-7) or
14 (MARS-14) abundant proteins. They also concluded that
depleting more proteins is not by deﬁnition better. The
MARS-14 column removed 7 extra proteins but showed no
substantialadvantageovertheMARS-7inimprovingpeptide
analysis/global protein identiﬁcations from plasma.
Recently, a creative way of depleting a sample was devel-
oped, the so-called hexapeptide library of combinatorial
peptide ligands. High abundant proteins are expected to
quickly saturate their speciﬁc aﬃnity ligands leaving non-
bound high abundant proteins to be washed away. In con-
trast, low and medium abundant proteins and peptides do
not saturate their ligands and hence are concentrated on the
beads. This technique has the advantage that peptides and
proteinsareadsorbedundernativeconditionsandthusallow
monitoring of their biological activity [68, 69], although its
eﬃcacy is still debated [70].
Limited comparative studies are published on the diﬀer-
entdepletionandenrichmentmethods.Inthesefewcompar-
isons, mostofthesemethods arefoundtobecomplementary
to each other. Typically, the methods compared all lead to
identiﬁcation of a number of peptides and proteins, a part of
which is generally identiﬁed by all methods under investiga-
tion and another part which has been identiﬁed uniquely in
a sample that was treated with one of the methods [58, 68].
The only exception to this is the comparison of dye-based
depletion to immunodepletion of albumin (see above). In
this case, immunodepletion invariably resulted in the most
eﬃcient enrichment of low abundant proteins and peptides
[62, 65, 66]. Recently, Polaskova et al. [71]c o m p a r e d6
depletioncolumns.They,however,didnotcomparebasedon
identiﬁcation of proteins but on number of spots found by
2DPAGEandalsotook intoaccountthecostsofallmethods.
When only looking at protein spots, they concluded that
one column (Seppro MIXED12-LC20, GenWay Biotech) had
the best overall performance leading to the largest number
of new proteins spots. A second column (multiple aﬃnity
removal column human 6, Agilent Technologies) in the same
study led to almost the same quality results, while being
cheaper and thence representing a more economical option
which could become the preferred method when budgets are
limited.6 Journal of Biomedicine and Biotechnology
2.5. Alkylation and Digestion. In those cases where larger
members of the peptidome need to be addressed, another
crucial part of sample pretreatment is alkylation and diges-
tion of the peptides/small proteins. This can be performed
prior to or after the previously described techniques, that is,
just before LC-MS/MS analysis.
To break the tertiary structure of peptides, disulﬁde
bridges have to be disrupted (reduced) and blocked to pre-
vent reoxidation. Breaking of disulﬁde bonds is traditionally
achieved using reducing agents such as dithiothreitol (DTT)
or tris(2-carboxyethyl)phophine hydrochloride (TCEP) [72,
73]. After reduction, the thiol groups are blocked, typi-
cally by alkylation, with iodoacetamide (IAM) being the
mostly used alkylating agent. Another alkylating agent is 2-
bromoethylamine (BrEA), which transforms cysteine into
S-aminoethyl cysteine, a pseudo-lysine, hereby creating an
extra cleavage site for proteolytic enzymes such as trypsin
[74, 75], which can be an advantage in certain cases.
When larger (poly)peptide members of the peptidome
are envisaged, a bottom-up approach, requiring proteolytic
digestion prior to mass spectrometric analysis, is sometimes
to be considered. Trypsin by far is the most used proteolytic
enzyme for the degradation of proteins or peptides. This
protease has the advantages of having a high cleavage
speciﬁcity and being stable in a wide range of conditions.
It cleaves C-terminal to arginine or lysine residues (except
where the subsequent amino acid in the parent sequence
is a proline). Thanks to the biological distribution of these
amino acids among all proteins, the resulting peptide masses
typically fall within the range required for analysis by mass
spectrometry. Some larger peptides or even proteins have
been described in literature that contain only 1 tryptic
cleavage site, producing a peptide still too large to be readily
detectedbymassspectrometry.Inthosecases,acombination
of 2 or more proteases and/or alkylating with BrEA i.s.o.
IAM, may be used to assist in peptide identiﬁcations.
Trypsin is very similar to chymotrypsin in primary structure,
however chymotrypsin prefers cleaving C-terminal to amino
acids with bulky aromatic residues such as phenylalanine,
tyrosine, and tryptophan [48, 76–79]. Also other sequence-
speciﬁcproteaseshavetheiradvantagesinviewofsubsequent
MS analysis of the resulting peptides. A good example is
metalloendopeptidase Lys-N, which guarantees a prominent
positive charge at the aminoterminus of the cleaved product
[80].
3. GeneralSample PreparationinPeptidomics
3.1. Ultraﬁltration. Ultraﬁltration is a rather easy and widely
used technique to fractionate a proteomics sample into
aLMW fraction (the “peptidome”) and aHMW fraction (the
rest of the “proteome”) by centrifugation [81]. For example,
in a recent study on CSF, Zougman et al. [81] demonstrated
the power of ultraﬁltration to separate neuropeptides from
the set of larger proteins present in CSF. The ultraﬁltrate low
molecular weight fraction of the CSF was directly separated
bynano-LC-MS/MS. Ultimately, this led to the identiﬁcation
of 563 peptides derived from 91 protein precursors. Several
of the identiﬁed peptides were found to carry features typical
of regulatory peptides. For example, they exhibited evidence
of being produced by proconvertase cleavage, having a
high cysteine content, bearing an aminoterminal pyrog-
lutamate and/or carboxyterminal amidation. Interestingly,
in the same study, a parallel proteome proﬁling by 1D
PAGE was performed, and this yielded 798 proteins. For
many of the identiﬁed neuropeptides in the ultraﬁltrate,
the corresponding precursor protein was not identiﬁed in
the proteome screen, which evidently demonstrates the
necessity of separating peptides from larger protein species.
Many diﬀerent devices are available, each with speciﬁc
molecular weight cut-oﬀ (MWCO) and type of membrane.
Depending on the sample and the experiment, diﬀerent
devices are preferred. Ultraﬁltration is not seldom reported
as a poorly reproducible technique, with possible removal of
proteins and peptides below and above the stated MWCO
[82–84].
To disrupt potential protein-protein/peptide interac-
tions, acetonitrile (ACN) is added to the sample before ultra-
ﬁltration. ACN this way improves the recovery of LMW
peptides [20, 85]. Harper et al. [86]i n v e s t i g a t e ds e v e r a l
factors which might inﬂuence the ultraﬁltration such as
centrifugation time and speed. In their study, slower speed
and longer time than advised by the manufacturer lead to
improved recovery of LMW proteins and peptides. However,
at the same time, also more HMW proteins appeared to pass
through the ﬁlters. Greening and Simpson [87]c o m p a r e d4
diﬀerent ultraﬁltration devices. They concluded that devices
with vertical or angular membrane conﬁguration reduce
membrane fouling, allowing continuous ﬂow rates, even
with high protein concentrations.
Ultraﬁltration units can also be used as “reactors” for
digestion of proteins and chemical modiﬁcations. This
approachisknownasﬁlter-aidedsamplepreparation(FASP)
and it can be used to combine the advantages of in-gel and
in-solution digestion [88, 89].
3.2. Organic Solvent Precipitation. The addition of organic
solvents to serum causes high molecular weight (HMW)
proteins to precipitate, leaving the LMW protein fraction—
including the peptides—in solution. By also adding ion-
pairing reagents such as triﬂuoroacetic acid, peptides, and
smaller proteins can be dissociated from high abundant
proteins, thereby facilitating their extraction [90–92]. In
general, proteins are precipitated by adding ice-cold acetone
or ACN. However, also other organic solvents can be used.
Tucholska et al. [82] compared several solvents for organic
precipitation and concluded that acetone precipitated the
serum proteins most completely. They found that methanol
was actually the least favorable solvent for precipitation as
it still contained the largest amount of albumin in solution.
Chertov et al. [90] report that the use of methanol also
leads to a much larger and less dense precipitate which was
more diﬃcult to separate from the supernatant. Polson et
al. [93] likewise compared several precipitation methods,
concluding that ACN is the most eﬃcient precipitant for
protein removal.
As an alternative to organic solvents, ammonium sulfate
(AS) can be used for precipitation of proteins. Although ASJournal of Biomedicine and Biotechnology 7
is a very eﬃcient precipitant, it can cause interface contami-
nation when combining with LC-MS [93].
Kawashima et al. [94] recently described a method for
diﬀerential solubilization. This method consists of 2 steps,
the ﬁrst of which denatures proteins and peptides and by
dropping the denatured sample in ice-cold acetone causes
all proteins and peptides to precipitate. In the second step,
the LMW proteins and peptides which dissolve in 70% ACN
containing 12mM HCl are separated from most of the other
proteins. When compared to normal organic precipitation
(with ACN) and ultraﬁltration, they conclude this method
gives a much better yield for low molecular weight peptide
extraction from human serum (see Figure 3).
3.3. Liquid Chromatography
3.3.1. Size Exclusion Chromatography. Another analytical
tool to separate LMW compounds from HMW compounds
is size exclusion chromatography (SEC). This is a widely
used technique for the puriﬁcation and analysis of synthetic
and biological polymers based on their size, which is not by
deﬁnition the same as their molecular weight. It separates
polysaccharides, nucleic acids but also proteins and peptides.
The material used for SEC consists of porous beads, which
either exclude the peptide/protein analytes from the internal
space or allow them to enter based on their size. Peptides
and smaller proteins, which can enter the beads, will move
at a slower rate through the column than bigger proteins
which cannot penetrate the beads, thus migrating faster. A
disadvantage of this technique is its low resolving power,
which can be improved by using it in combination with
other separations, such as in multidimensional separation
approaches (see below). Other drawbacks are the high elu-
tion volumes which cause dilution of the sample, increased
costs when having to use multiple columns, and the need
for high sample loads [44]. In literature, some reports have
appeared on the use of a one-step peptidome enrichment
method based on SEC [15, 95, 96]. Ueda et al. [15]
mention the separation of over 12,000 molecules by using
SEC followed by C18 nano-LC-MS. They show that their
procedure allows a precise separation of serum proteins and
peptides based on their molecular weights. Tucholska et al.
[82] showed that SEC can be used to remove substantial
amounts of albumin from serum (although a small amount
could still be detected in the depleted fraction). Hu et al. [97]
performed a comprehensive peptidome analysis of mouse
liver by combining SEC prefractionation with nano-LC-
MSMS. From the low molecular weight fractions (<3kDa)
that eluted from the SEC column, 1181 unique peptides
originating from 371 proteins were identiﬁed [97].
3.3.2.ReversedPhaseChromatography. Reversed phase liquid
chromatography (RPLC) separates molecules based on dif-
ferences in their hydrophobicity. The mobile phase is a water
and nonpolar organic solvent mixture, whereas the station-
ary phase is hydrophobic. Factors inﬂuencing the selectivity
and resolution of separation include the hydrophobic ligand,
the particle size, sample volume, column length, and pH.
The most commonly used hydrophobic ligand for peptide
analysis is C18, but C4 and C8 are preferred for the larger
peptides and proteins. In terms of peptides extraction,
the solid phase material can be packed in syringe-shaped
cartridges, or even in 96-well plate formats, which allows
for high throughput extractions. Another advantage of
this technique is its capability to desalt samples, which is
desirable prior to mass spectrometric analysis [43, 44, 98,
99].Inproteomics/peptidomicsanalysis,nowadays,capillary
reversed phase columns with an internal diameter of 75 to
100μm are commonly used, mainly because of the increased
sensitivity this oﬀers. Because of these small columns, low
ﬂow rates have to be used, without decreasing the sensitivity,
and (often environmentally unfriendly) solvents are saved.
Reducing the particle size to 2μm or less allows the use of a
wider variety of linear velocities while maintaining accept-
able chromatographic resolution in substantially reduced
analysis times. This, however, requires new hardware since
typical HPLC systems generally are not able to handle the
high pressures required to pump the mobile phase through
a column packed with such minute particles. Ultrahigh-
pressure LC (UPLC) systems have been developed for this
purpose, allowing pressures of 400 bar and higher. Thanks to
the greater analytical power of UPLC, downscaling of sample
volumes and increasing the throughput of sample handling
have become possible [98, 100–103].
3.3.3. Ion Exchange Chromatography. Ion exchange chro-
matography (IEX) separates peptides (and proteins) based
on their charge in a speciﬁc salt environment and pH of the
mobilephase.TwotypesofIEXexist,namely,cationoranion
exchange (respectively CX and AX). IEX has a disadvantage,
being the use of salts which makes the eluate incompatible
with MS. The use of salts can also lead to irreversible peptide
or protein absorption to the resin, resulting in sample
loss. The principles of IEX are well understood, and other
advantages include the high resolution that can be achieved,
high capacity, selectivity, and robust operation.
Usually, simple salt buﬀers are suﬃcient and concentra-
tions are used in a deﬁned range, in which the so-called
salting-in eﬀect on proteins is observed. This is the range
where a protein becomes more soluble with increasing salt
concentration. Cation exchangers are negatively charged,
and anion exchangers; are positively charged. Above its
pI, a protein is negatively charged and binds to an anion
exchanger; below its pI, it is positively charged and binds
to cation exchangers. The ion exchanger itself behaves like
an acid or base, and the disproportionation of the charges
depends on the pH. Strong ion exchangers behave like a
strong acid or base and do not change the charge within
a wide range of pH, whereas weak ion exchangers do. This
p r o p e r t yc a na l s ob ee x p l o i t e dt og a i ns e l e c t i v i t yo rb y
applying pH gradients for elution [44, 105, 106].
3.3.4. Restricted Access Material. Restricted access material
(RAM) has been described for use in the separation of large
biomolecules and the extraction of LMW analytes. RAM
c o u l db ec o n s i d e r e dt ob ea n“ u p g r a d e ”o fn o r m a ls i z e
exclusion material. The outer surface of the RAM particles is
coated with a protective, nonadsorptive hydrophilic packing,8 Journal of Biomedicine and Biotechnology
16.9
2.5
6.2
8.2
10.7
14.4
(
k
D
a
)
Untreated serum
0.5 µL
Enriched LMW proteins/peptides
from 5 µL serum
DS OP UF
Figure 3: Comparison of the yield of low molecular weight protein/peptide extraction from serum by means of diﬀerential solubilization
(DS), organic precipitation (OP), and ultraﬁltration (UF). All techniques eﬀectively remove the high molecular weight serum protein,
whereas recovery of LMW proteins/peptides is highest with DS. Reprinted with permission from Kawashima et al. [94]. Copyright 2011
American Chemical Society.
while the surface of the pores can be coated with a variety
of diﬀerent aﬃnity matrices [107]. In principle, it prevents
access of macromolecules (e.g., proteins) to the bonded
phase in the pores, which can be compared to the size
exclusion process. Simultaneously, LMW target compounds
(such as peptides) are selectively retained on the aﬃnity
matrix in the pores [108, 109].
The most used type of internal selection material is
strong cation exchange (SCX) as this type of material is
highly suitable for the Online extraction of target peptides
from complex biological samples such as plasma [110,
111]. The method allows repetitive, direct injections of
untreated sample matrices and can also handle higher injec-
tion volumes in comparison to SEC [95, 98]. Also, this
method allows for automation of process. A few setups
have been described, in which RAM is even used in an
Online LC-MS/MS setup [108, 110–113]. This possibility
is an important advantage of the RAM technology. Rieux
et al. [113] even described the use of a macroscopic RAM
cartridge Online with nano-LC-MS for the quantiﬁcation
of a peptide analyte in samples containing high amounts
of bovine serum albumin (BSA). Although the separation
process can be automated, important parameters in RAM
chromatography, such as loading ﬂow rate, pH, and amount
of dilution and injected volume should be optimized as
they have a large eﬀect on the amount of adsorbed peptides
and proteins as well as on their recovery from the column.
The use of RAM has been demonstrated for the analysis of
peptides in complex biological matrices [114]. For example,
Machtejevras et al. [108] isolated and detected more than
1500peptidesandproteinfragmentsfromonly3mLofurine
using an online RAM-SCX system.
3.3.5. Multidimensional. Because of the high complexity of
biological samples, often a single fractionation or separation
step is insuﬃcient. Therefore, several techniques can be
combined to what is referred to as a multidimensional sepa-
ration. Combining 2 (diﬀerent) separation techniques leads
to an increased number of peptides measurable, an enlarged
overall dynamic range and thus an improved peptidome
coverage. A multidimensional approach can be achieved
both oﬄine and online. For the oﬄine separation, fractions
are collected after the ﬁrst dimension, which are later
reinjected into the second dimension separation. In between
both steps, the fractions can be manipulated if necessary. A
disadvantageofthismethodisthepotentialsamplelosswhen
transferring between both dimensions. When doing Online
multidimensional separation, the samples are automatically
transferred from the ﬁrst to the second dimension. A
drawback of this approach is that both dimensions have
to be compatible. Also the solvents should not cause salt
precipitation or immediate elution of the compounds in
the second dimension. Most often, RPLC is the second
dimension for its high speed, desalting capability, and
compatibility with mass spectrometry [19, 43, 115–118].Journal of Biomedicine and Biotechnology 9
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Figure 4: Eﬀect on the number of detected (neuro)peptides (from mouse hypothalamus) by postmortem time (time between tissue col-
lection and heat denaturation/stabilization) [104]. (a) Number of detected peptides by nano-LC ESI MS rapidly increases with postmortem
time. (b, c) Two-dimensional peptide displays of control group and 10min postmortem group, respectively. Picture adapted from Sk¨ old
et al. [104].
4. Sample Quality:Preservingthe
Integrityofthe Peptidome
It is clear that, besides selecting the best methodology to
comprehensively separate peptides from a biological mix-
ture, an essential part of peptidomics sample preparation is
thepreservationoftheintegrityoftheinvivopeptidome.Itis
capital to prevent all types of peptide degradation through-
out the procedure. Various protease inhibitor cocktails can
be introduced in the sample as early as viable, to try and
inhibit ubiquitous peptide degrading enzymes [118, 119].
In addition, peptidomics samples are traditionally snap-
frozen, at a very low temperature as soon as possible,
and subsequently freeze dried. Yet, such strategies donot
always appear adequate (rapid enough) to prevent bioactive
peptide degradation (several peptidases “survive” repeated
freeze-thaw cycles). This has clearly been demonstrated for
the (neuro)peptidome, which appears particularly sensitive
to rapid ex vivo (postsampling) degradation (Figure 4).
Microwaves were found to be eﬀective to rapidly and
permanently inactivate enzymes [104, 120], although poorly
controllable. An elegant automated instant thermal denat-
uration system, based on conductive heating, at controlled
pressure under vacuum, was developed for successful and
reproducible blocking of ex vivo sample degradation, thereby
stabilizing the peptidome (Denator, Gothenburg, Sweden).
Depending on the sample-origin-speciﬁc “indicator pep-
tides” can be used to monitor/assess the sample quality, prior
to analysis. One example is the post mortem appearance in
mammalian neuronal tissue of the peptide stathmin 2–20,
which indicates proteolytic degradation [104].
5. Conclusion andFuturePerspective
In general, it can be concluded that sample preparation for
the purpose of capturing the peptidome from bioﬂuids still
has room for improvement, and a single generic methodol-
ogyisnot(yet)available.Manymethodsexistfortheanalysis
of proteins which can, sometimes with minor adjustments,
be used for peptides as well. Ideally, sample preparation/
handlingshouldbeminimal,butcurrentmassspectrometers
are not quite able to handle complex biological matrices.
Manufacturers of mass spectrometry instrumentation are
continually improving the performance of their systems. For
example, over the last decades, the sensitivity of mass spec-
trometers has tremendously increased, where at the moment
theyhavereachedthelowattomolelevel.Also,improvements
in mass accuracy and advances in peptide fragmentation
techniques permit us now to obtain highly conﬁdent iden-
tiﬁcation and even fully de novo sequence novel peptides.
Despite these ongoing improvements, it should be noted
that at the moment, a peptidomics analysis MS system that
can operate without sample preparation is still far way,
which is mainly due to the high complexity of the biological
matrices. The biggest bottleneck in bioﬂuid research is the
highdynamicrangeatwhichtheproteins/peptidesoccur.For
example, albumin concentration is ∼40mg/mL in serum,
whereas the concentration of biologically active compounds
such as cytokines is ∼1pg/mL. The removal of abundant
plasma/serum proteins by dye- or immuno-based depletion
is at moment the most popular strategy to “mine” deeper
into proteome/peptidome. However, one should also realize
that albumin and other major proteins in blood plasma
carry some number of other “adsorbed” peptides and even
small proteins on their surface, and, therefore, these will
risk to get lost during this depletion step. The precipitation
of the abundant protein fraction in human bioﬂuids by
organic solvents has probably the longest history among
all the methods used for abundant protein removal. This
procedure is still one of the most eﬀective methods as it
permits fast and, although not always highly reproducible,
cheap obtainment of the peptide fraction for their analysis
by mass spectrometry.10 Journal of Biomedicine and Biotechnology
Several other analytical strategies are at hand that aid
in the reduction of the complexity of samples, and some
speciﬁcally focus on capturing the LMW fraction, that is,
the smaller proteins and peptides from the bulk of larger
proteins, for example, ultraﬁltration as method to split a
sample into a proteome and a peptidome fraction. However,
one should be aware that several studies have shown
dramatic diﬀerences in the performance (both in terms of
reproducibility, recovery, and separation) of commercially
available ultraﬁltration devices.
Amorepreferredanalyticaltooltoseparatebiomolecules
onbasisofsizeisliquidchromatography.Sizeexclusionchro-
matography and more speciﬁcally restricted access material
have high potential in peptidome research, due to their high
resolution and selectivity. Reversed phase and ion exchange
chromatography are highly suitable for peptide fractionation
and separation. These last two chromatography techniques
also can be miniaturized, making them even more favorable
in term of sensitivity.
In general, as sample preparation is often time con-
suming and laborious, high-throughput and automated
approaches are highly desirable. Whereas up to now, when
doing multidimensional LC, the ﬁrst dimension led to the
collection of fractions in an oﬄine setup, online multi-
dimensional LC setups gain popularity. Also the column
material used in liquid chromatography is continually being
improved, and the possibility of combining separation based
on diﬀerent physicochemical properties, such as RAM, is a
big step forward. Even though it usually takes some eﬀort
to completely set up and optimize an LC-based method,
once done, it usually results in a very robust and reliable
technique, which can be fully automated. Also miniaturiza-
tion is an important aspect of the evolution, as a miniature
system (e.g., lab-on-a-chip) will allow for lower amounts
of solvents and less complicated equipment to be used,
decreasing the cost of an analysis. With the development
of new sample pretreatment methods and lower detection
limits on mass spectrometers, future peptidome analysis
will aid substantially in biological and medical research, for
example, by discovering new biomarkers and uncovering
novel signaling pathways.
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